Literature DB >> 19164805

Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus.

Angela C Rutledge1, Wei Qiu, Rianna Zhang, Rita Kohen-Avramoglu, Nina Nemat-Gorgani, Khosrow Adeli.   

Abstract

OBJECTIVE: In lipid-poor states, the ubiquitin-proteasomal pathway rapidly degrades misfolded apolipoprotein B100 (apoB) cotranslationally, although the mechanism of delivery from the ER to cytosolic proteasomes is poorly understood. Here we demonstrate key roles of BiP, an ER luminal chaperone, and p97, a cytosolic ATPase anchored to the ER membrane, in the targeting of apoB for proteasomal degradation. METHODS AND
RESULTS: Using coimmunoprecipitations, we observed associations of apoB with BiP, p97, Derlin-1, VIMP, and the E3 ubiquitin ligase Hrd1 in HepG2 cells. BiP and p97 were found to bind apoB cotranslationally. Expression of C-terminal truncated apoB molecules in COS-7 cells showed an N-terminal region outside apoB15 and a C-terminal region found in apoB72 were required for BiP and p97 binding, respectively. Interestingly, overexpression of dominant negative p97 demonstrated that the ATPase activity of p97 was essential for proteasomal degradation of apoB but not for apoB binding. However, p97 activity did not appear to affect the N terminus of apoB, which may be cleaved before degradation.
CONCLUSIONS: These data suggest that p97 and BiP play critical roles in the cotranslational delivery of apoB to proteasomes and formation of a degradative complex. Proteasomal degradation appears to selectively target apoB molecules with large C-terminal domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164805     DOI: 10.1161/ATVBAHA.108.181859

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.

Authors:  Eric A Fisher; Neeraj A Khanna; Roger S McLeod
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

2.  Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.

Authors:  Joan Oliva; Samuel W French; Jun Li; Fawzia Bardag-Gorce
Journal:  Exp Mol Pathol       Date:  2012-03-16       Impact factor: 3.362

Review 3.  Endoplasmic reticulum quality control in lipoprotein metabolism.

Authors:  Cari M Koerner; Benjamin S Roberts; Saskia B Neher
Journal:  Mol Cell Endocrinol       Date:  2019-08-20       Impact factor: 4.102

Review 4.  Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Authors:  Ignat Printsev; Daniel Curiel; Kermit L Carraway
Journal:  J Membr Biol       Date:  2016-10-14       Impact factor: 1.843

Review 5.  The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways.

Authors:  Edward A Fisher
Journal:  Biochim Biophys Acta       Date:  2012-02-10

6.  The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).

Authors:  Linda Sasset; Gianluca Petris; Francesca Cesaratto; Oscar R Burrone
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

Review 7.  The Gp78 ubiquitin ligase: probing endoplasmic reticulum complexity.

Authors:  Pascal St Pierre; Ivan R Nabi
Journal:  Protoplasma       Date:  2011-11-03       Impact factor: 3.356

8.  The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis.

Authors:  Kezhong Zhang; Shiyu Wang; Jyoti Malhotra; Justin R Hassler; Sung Hoon Back; Guohui Wang; Lin Chang; Wenbo Xu; Hongzhi Miao; Roberta Leonardi; Y Eugene Chen; Suzanne Jackowski; Randal J Kaufman
Journal:  EMBO J       Date:  2011-03-15       Impact factor: 11.598

Review 9.  Endoplasmic Reticulum-Associated Degradation and Lipid Homeostasis.

Authors:  Julian Stevenson; Edmond Y Huang; James A Olzmann
Journal:  Annu Rev Nutr       Date:  2016-05-26       Impact factor: 11.848

10.  Stringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates.

Authors:  Riccardo Bernasconi; Carmela Galli; Verena Calanca; Toshihiro Nakajima; Maurizio Molinari
Journal:  J Cell Biol       Date:  2010-01-25       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.